unknown
Stage
About
Conceivable Life Sciences develops AURA, an automation-assisted IVF lab that combines precision robotics, advanced optics and proprietary software to automate embryology workflows and improve IVF outcomes. The system generates standardized process data, is being validated in an IRB-approved clinical study, and the company reports over 30 live births and more than 60 pregnancies to date.
Explore Conceivable Life Sciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.